Cargando…
Hyperphosphatemic Familial Tumoral Calcinosis With Galnt3 Mutation: Transient Response to Anti‐Interleukin‐1 Treatments
Hyperphosphatemic familial tumoral calcinosis (HFTC) is a rare autosomal recessive disease caused by mutations in genes involved in phosphate homeostasis and characterized by high serum phosphate concentration and occurrence of ectopic calcifications. Management of the disease includes lowering of p...
Autores principales: | Dauchez, Astrid, Souffir, Camille, Quartier, Pierre, Baujat, Geneviève, Briot, Karine, Roux, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6659445/ https://www.ncbi.nlm.nih.gov/pubmed/31372591 http://dx.doi.org/10.1002/jbm4.10185 |
Ejemplares similares
-
Identification of two novel mutations in the GALNT3 gene in a Chinese family with hyperphosphatemic familial tumoral calcinosis
por: Sun, Lihao, et al.
Publicado: (2016) -
Familial Hyperphosphatemic Tumoral Calcinosis
por: Saifuddin, Mohammad, et al.
Publicado: (2023) -
Hyperphosphatemic Familial Tumoral Calcinosis in Two Siblings with a Novel Mutation in GALNT3 Gene: Experience from Southern Turkey
por: Kışla Ekinci, Rabia Miray, et al.
Publicado: (2019) -
A case of hyperphosphatemic familial tumoral calcinosis due to maternal
uniparental disomy of a GALNT3 variant
por: Nishimura-Kinoshita, Naoko, et al.
Publicado: (2023) -
Long-term clinical outcome and phenotypic variability in hyperphosphatemic familial tumoral calcinosis and hyperphosphatemic hyperostosis syndrome caused by a novel GALNT3 mutation; case report and review of the literature
por: Rafaelsen, Silje, et al.
Publicado: (2014)